A reduced risk of nocturnal hypoglycemia is among the advantages….
Read More »Diabetic Macular Edema (DME) Risk Higher for Non-Hispanic African American Patients
Risk is also higher for those who have had diabetes longer and have higher HbA1c levels….
Read More »Diet and Physical Activity Reduce Inflammatory Markers in Type 2
Both diet and diet plus physical activity interventions reduced inflammatory markers soon after type 2 diagnosis….
Read More »Sensor Implant Measures Blood pH in Type 1 Diabetes
The device, only tested in mice, also can release insulin to prevent acidosis….
Read More »CPAP Lowers BP and A1c in Patients with Obstructive Sleep Apnea and Type 2 Diabetes
Researchers also found that Quality of Life improved and costs were lowered….
Read More »Beta-Adrenergic Blockade Effects on Glucose Counterregulation in Advanced T2DM and Beta-Cell Failure
At normoglycemia, beta-adrenergic blockade may cause increased insulin sensitivity….
Read More »The Safety and Use of Oral Methazolamide in Type 2 Diabetes
Methazolamide, a carbonic anhydrase inhibitor, is a medication used to treat increased pressure inside the eye due to glaucoma….
Read More »Insulin Resistance’s Effects on Tissue Iron Stores and Cognitive Performance
BIO (brain iron overload) could be a potentially useful MRI biomarker for insulin resistance and obesity-associated cognitive dysfunction….
Read More »Empagliflozin (Jardiance) SGLT-2 Inhibitor Now Available in Pharmacies
The glucose-reducing drug empagliflozin (Jardiance) now has approval from the FDA after the drug maker corrected manufacturing problems that caused the agency to say “no” in March…. The sodium glucose cotransporter 2 (SGLT2) is indicated for improving glycemic control in adults with type 2 diabetes in conjunction with diet and …
Read More »Hypertension Control Can Prevent Renal Damage in Diabetics
Elevated blood pressure is associated with an increased risk of renal damage in patients with type 2 diabetes, especially if they have poor glycemic control….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.